THERATARGET

Address

615 Arapeen Drive, Suite 302-Y
Salt Lake City, UT, 84108-1289

Information

DUNS: 828787379
# of Employees: 0

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. In-situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): This Phase I proposal addresses the significant need for improved treatment options for patients with liver cancer, the fifth highest incidence of cance in the wo ...

    STTRPhase I2012Department of Health and Human Services
  2. Backbone Degradable Polymer-drug Conjugates for the Treatment of Ovarian Cancer

    Amount: $148,304.00

    DESCRIPTION (provided by applicant): This Phase I proposal details the rationale and the research plan for the synthesis and characterization of targeted, backbone degradable, long-circulating polymer ...

    STTRPhase I2011Department of Health and Human Services
  3. Targeted Polymeric Combination Delivery for Treatment of Ovarian Cancer

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): This Phase I proposal details the rationale and the research plan for the synthesis and characterization of a polymeric delivery system that will deliver two antic ...

    STTRPhase I2010Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government